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Abstract
Background: Little evidence supports the use of any one vas occlusion method. Data from a
number of studies now suggest that there are differences in effectiveness among different occlusion
methods. The main objectives of this study were to estimate the effectiveness of vasectomy by
cautery and to describe the trends in sperm counts after cautery vasectomy. Other objectives were
to estimate time and number of ejaculations to success and to determine the predictive value of
success at 12 weeks for final status at 24 weeks.
Methods:  A prospective, non-comparative observational study was conducted between
November 2001 and June 2002 at 4 centers in Brazil, Canada, the UK, and the US. Four hundred
men who chose vasectomy were enrolled and followed for 6 months. Sites used their usual cautery
vasectomy technique. Earlier and more frequent than normal semen analyses (2, 5, 8, 12, 16, 20,
and 24 weeks after vasectomy) were performed. Planned outcomes included effectiveness (early
failure based on semen analysis), trends in sperm counts, time and number of ejaculations to
success, predictive value of success at 12 weeks for the outcome at 24 weeks, and safety evaluation.
Results: A total of 364 (91%) participants completed follow-up. The overall failure rate based on
semen analysis was 0.8% (95% confidence interval 0.2, 2.3). By 12 weeks 96.4% of participants
showed azoospermia or severe oligozoospermia (< 100,000 sperm/mL). The predictive value of a
single severely oligozoospermia sample at 12 weeks for vasectomy success at the end of the study
was 99.7%. One serious unrelated adverse event and no pregnancies were reported.
Conclusion: Cautery is a very effective method for occluding the vas. Failure based on semen
analysis is rare. In settings where semen analysis is not practical, using 12 weeks as a guideline for
when men can rely on their vasectomy should lessen the risk of failure compared to using a
guideline of 20 ejaculations after vasectomy.
Background
In spite of the vast published literature on vasectomy,
until recently there has been little evidence to support the
use of any one occlusion method over others [1,2]. Data
from a number of studies now suggest that there are dif-
ferences in effectiveness among the different occlusion
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methods. For example, several recently published studies
have found higher than expected failure rates for vasec-
tomy by ligation and excision, especially when used with-
out fascial interposition. These reports suggest that
ligation and excision without fascial interposition may
not be a satisfactory occlusion technique [3-8].
Some published evidence suggests that cautery may be a
more effective occlusion technique than some of the other
methods currently being used [1]. In addition, at the time
our study was being carried out, the Royal College of
Obstetricians and Gynaecologists in the U.K. recom-
mended the use of cautery (or ligation and excision with
fascial interposition), although they noted that the evi-
dence in favor of cautery was at the lowest level, i.e. expert
opinion [9].
In the United States, cautery is the most commonly used
vasectomy occlusion method [10]. However, in resource
poor countries, where 75% of the world's vasectomies are
done, it is much less common–ligation and excision being
the most widely used occlusion technique, especially in
large public-sector programs [11].
The primary objectives of this study were to: estimate the
effectiveness of cautery as currently performed at four dif-
ferent sites practicing slightly different techniques, using
standardized semen analysis methods, and to describe the
trends in sperm counts after vasectomy with cautery. Sec-
ondary objectives were to: estimate the time and number
of ejaculations to success among men who were vasect-
omized using cautery and to describe the predictive value
of success at 12 weeks for the final outcome at 24 weeks.
Methods
We conducted a prospective, non-comparative observa-
tional study of vasectomy by cautery at four centers: two
family planning clinics, one in Salvador, Bahia, Brazil and
the other in Oxford, U.K. ; and two university hospitals,
one in Québec City, Québec, Canada and the other in
Seattle, WA, U.S. No new methods were introduced. The
only study intervention was to obtain earlier and more
frequent semen analyses than were normally performed.
Enrollment began in November 2001 and all follow-up
was completed by June 2002. The study was approved by
institutional review boards of Family Health International
and each participating center.
Four hundred men who chose vasectomy as their method
of contraception were recruited for the study at the four
centers (100/center). After obtaining informed consent,
men were screened for eligibility. In addition to meeting
local clinic requirements for vasectomy, study admission
criteria included: freely consenting to participate, willing
to provide semen samples according to the follow-up
schedule, willing to use an alternate contraceptive until
success was confirmed, agreeing to provide follow-up
information such as serious adverse events and preg-
nancy, agreeing to maintain a record of all ejaculations
occurring between follow-up visits, able to understand the
study procedures and requirements, no condition which
in the opinion of the principal investigator contraindi-
cated participation, and no history of previous vasectomy.
Vasectomy procedures and follow-up
Each study site used their usual vasectomy technique. A
total of 14 surgeons, all experienced with vasectomy using
cautery, participated in the study (one at the U.S. site, two
each at the Brazil and Canada sites, and nine at the U.K.
site). As this was an observational study, no attempt was
made to standardize the vasectomy techniques among
sites or surgeons. Three of the sites used the no-scalpel
(NSV) approach to the vas (Brazil, Canada and the U.S.)
and the other site used a scalpel approach with two lateral
incisions (U.K.). The occlusion techniques used varied
among the sites in terms of type of cautery (thermal or
electrocautery), open vs. closed ended, whether or not a
portion of the vas was excised, and use of fascial interpo-
sition (Figure 1). Follow-up semen analysis was carried
out at 2, 5, 8, 12, 16, 20 and 24 weeks after vasectomy.
Participants were asked to record all ejaculations between
semen analyses on a wallet-sized card, which was turned
in to study personnel at each follow-up.
Semen analysis
All sites used standardized laboratory methods for deter-
mining sperm concentration of semen samples using
adapted World Health Organization techniques [12].
Ejaculated semen was first examined by phase-contrast
microscopy (X400) to estimate sperm concentration and
then diluted with water. Sperm concentration was deter-
mined using a Neubauer hemocytometer. The laborato-
ries conducted periodic quality control tests.
Outcome measures
Study outcomes included: effectiveness (i.e. early failure
rate), trends in sperm counts, time and number of ejacu-
lations to success, predictive value of success at 12 weeks
for the outcome at 24 weeks, and safety based on serious
adverse events.
The primary definition of vasectomy success was severe
oligozoospermia–less than 100,000 sperm/mL in two
consecutive specimens at least two weeks apart with all
subsequent samples showing only rare sperm. An addi-
tional definition of vasectomy success was azoospermia–
two consecutive specimens with no sperm at least two
weeks apart with all subsequent samples showing only
rare sperm. Early failure was defined as not meeting the
definition of success during the 24 weeks of follow up andBMC Urology 2004, 4:10 http://www.biomedcentral.com/1471-2490/4/10
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having greater than 10 million sperm /mL at week 12 or
later after vasectomy. In addition, clinician declared fail-
ure–obvious failure based on large numbers of motile
sperm–prior to 12 weeks was also classified as early
failure.
Statistical methods
The sample size calculation was focused on the estimation
of the failure rate with adequate precision based on an
exact binomial 95% confidence interval. A sample size of
400 was considered sufficient to adequately estimate the
Occlusion techniques used at the 4 study sites Figure 1
Occlusion techniques used at the 4 study sites. Dotted outline indicates segment of the vas excised. Darkened vas lumen 
indicates cauterized segment. Fascial interposition involves placing a layer of the vas sheath between the 2 cut ends of the vas 
to form a tissue barrier.
Oxford, U.K. 
Electro-cautery
Seattle, U.S. 
Thermal cautery & 
fascial interposition
Salvador, Brazil
Electro-cautery
Quebec City, Canada 
Thermal cautery & 
fascial interpositionBMC Urology 2004, 4:10 http://www.biomedcentral.com/1471-2490/4/10
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failure rate assuming that the rate would not be larger
than 3% and allowing for 10% lost to follow-up.
The overall failure rate was estimated based on an exact
binomial 95% confidence interval. Only men who pro-
vided semen samples for at least 12 weeks or were
declared a vasectomy failure by a site clinician prior to 12
weeks were included in this analysis. The sperm concen-
tration patterns for the identified failures were examined
in more detail. The sperm concentrations for all partici-
pants in the study were classified at each time point into
several categories ranging from azoospermia to more than
10 million sperm per mL to study the progression towards
success during the 24 weeks of follow up. Kaplan-Meier
product limit estimates of the probabilities of vasectomy
success at each scheduled week of follow-up through week
24 and their 95% confidence intervals were produced for
severe oligozoospermia and azoospermia outcomes.
Peto's standard error [13] was used to compute the 95%
confidence intervals. Similar life-table analysis was con-
ducted to study the number of ejaculations needed to
achieve success instead of time.
Cox proportional hazard regressions were fitted to study
the effect of age (two age groups: less than 35, and 35 and
older. Further breakdown into other age groups did not
provide additional useful information), site, and cumula-
tive number of ejaculations during follow-up on time to
success. Cumulative number of ejaculations was treated as
a time-dependent covariate. Hazard ratios (HR) are pre-
sented in the results.
Finally, given the interest in simplifying guidelines for fol-
low-up after vasectomy, we estimated the predictive value
of a single sample showing severe oligozoospermia at 12
weeks after vasectomy for vasectomy success at the end of
the 24 weeks of follow-up. Only participants who pro-
vided a semen sample at 12 weeks and completed the
study were included in this analysis.
Results
Baseline characteristics of the 400 men enrolled in the
study are shown in Table 1. Median age of participants at
the time of vasectomy was 36 years (range 25–62). Final
disposition of study participants was as follows: out of
400, 364 (91%) completed the 24 weeks of follow-up; 19
(4.8%) discontinued early, primarily for personal reasons;
and 17 (4.2%) were lost to follow-up. No pregnancies
were reported during the study period and only one seri-
ous adverse event occurred, a case of measles unrelated to
the vasectomy procedure.
Of the 400 participants enrolled, 11 did not provide any
semen analysis data after vasectomy and were thus
excluded from further analysis. The remaining 389 men
contributed data to the analyses of trends in sperm counts
and time/number of ejaculations to success. Eleven addi-
tional men had less than 12 weeks of follow-up without
having been declared a failure by a study site clinician.
They were excluded from the effectiveness analysis and
thus data from 378 men were used for the effectiveness
analysis presented here.
The overall failure rate was 0.8% (3/378; 95% confidence
interval 0.2, 2.3). The three failures occurred at two study
sites. Sperm concentration profiles for the three partici-
pants with a vasectomy failure are shown in Figure 2. One
participant (Participant 1 in Figure 2) appeared to have
been a technical failure, with vas occlusion not success-
fully carried out on one or both sides. His sperm concen-
tration was in the normal range at the 2 week follow-up
Table 1: Baseline characteristics of study participants (N = 400; 100 per center)
Center
Brazil Canada US UK Total
C h a r a c t e r i s t i c N%N%N%N%N%
Age group < 30 20 20.0 8 8.0 9 9.0 4 4.0 41 10.3
30–34 37 37.0 36 36.0 28 28.0 16 16.0 117 29.3
35–39 32 32.0 30 30.0 25 25.0 38 38.0 125 31.3
4 0 + 1 11 1 . 02 62 6 . 03 83 8 . 04 24 2 . 0 1 1 7 2 9 . 3
Married/partnered 100 100.0 87 87.0 93 93.0 98 98.0 379 94.5
Number of children 0 00 . 066 . 066 . 044 . 0 1 6 4 . 0
1 5 5.0 14 14.0 18 18.0 7 7.0 44 11.0
2 4 84 8 . 05 15 1 . 05 05 0 . 05 25 2 . 0 2 0 1 5 0 . 3
3+ 47 47.0 29 29.0 26 26.0 37 37.0 139 34.8
Prior condom use No 47 47.0 41 41.0 52 52.0 44 44.0 184 46.0
Y e s5 3 5 3 . 05 95 9 . 04 84 8 . 05 65 6 . 0 2 1 6 5 4 . 0BMC Urology 2004, 4:10 http://www.biomedcentral.com/1471-2490/4/10
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and remained high through 8 weeks after vasectomy, at
which time he requested and had another vasectomy. He
was discontinued from the study at that point. The other
two participants (Participants 2 and 3 in Figure 2) showed
semen analysis patterns consistent with very early recanal-
ization–drops in sperm concentration to very low num-
bers followed by slow, steady increases to the normal
range.
To examine trends in sperm counts over the 24 week fol-
low-up period, semen analysis results at each time point
were divided into six categories from azoospermia to 10
million or more sperm/mL (Figure 3). At the 2 week fol-
low-up, 49.7% (190/382) of participants showed
azoospermia or severe oligozoospermia, rising to 96.4%
(354/367) by the 12 week half way point of the study, and
eventually reaching 99.4% (361/363) by the 24 week
study endpoint. This analysis considers the available data
for all men at each follow-up week and, unlike the Kap-
lan-Meier estimates presented below, ignores the classifi-
cation of each participant at previous weeks. For example,
in Figure 3, a participant may be classified in a lower
sperm concentration category at a particular follow-up
week, and later on, be classified in a higher sperm concen-
tration category.
Kaplan-Meier estimates of the cumulative event probabil-
ities for time to vasectomy success (defined as severe oli-
gozoospermia and as azoospermia) are presented in Table
2. The cumulative probability for vasectomy success was
essentially identical for both endpoints at 24 weeks after
vasectomy. However, men reached success sooner when
severe oligozoospermia was used as the definition of suc-
cess compared to when azoospermia was used (e.g. at 12
weeks follow-up 95% vs. 85% success, respectively).
Median time to success was within the 5 week time win-
dow for both oligozoospermia and azoospermia.
All three covariates examined–age, site, and cumulative
number of ejaculations during follow-up–had a signifi-
cant effect on time to vasectomy success defined as severe
oligozoospermia. Younger men were likely to reach suc-
cess earlier than older men (HR = 1.29, p = 0.02, see Table
2 for success rate estimates at different time points), but
cumulative success rates at the end of the study did not
differ by age. In addition, compared to participants from
Brazil, those from the U.S. (HR = 1.95, p < 0.0001) and
Sperm counts for the 3 participants with vasectomy failure Figure 2
Sperm counts for the 3 participants with vasectomy failure. The pattern for Participant 1 is consistent with technical 
failure, while those of Participants 2 and 3 suggest early recanalization.
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the U.K. (HR = 1.41, p = 0.02) reached success signifi-
cantly earlier, but those from Canada (HR = 1.21, p =
0.20) did not. The differences in the success rates by center
were most apparent prior to the 12-week visit (data not
shown). Finally, a higher number of cumulative ejacula-
tions during the follow-up period played a role in acceler-
ating occurrence of success (HR = 1.02, p = 0.007). Similar
results were seen when success was defined as azoosper-
mia (see Table 2; data on site and cumulative number of
ejaculations during follow-up not shown).
Kaplan-Meier estimates of the cumulative event probabil-
ities for number of ejaculations to vasectomy success
(defined as severe oligozoospermia) reached 98.7 per 100
men (95% CI 97.4, 100.0) at 65 ejaculations. By 10 ejac-
ulations after vasectomy, nearly 50% of men were vasec-
tomy successes, at 20 ejaculations 77% were, and by 35
ejaculations over 90% were. The median number of ejac-
ulations to severe oligozoospermia was 12.
The predictive value of a single semen sample showing
severe oligozoospermia at 12 weeks for vasectomy success
at the end of the study (using the oligozoospermia defini-
tion for success) was 99.7%. In other words, nearly all
men who showed severe oligozoospermia at 12 weeks
after vasectomy were vasectomy successes at the end of the
24 weeks of follow-up.
Discussion
Our results indicate that cautery is a highly effective and
safe method to occlude the vas for vasectomy. Results of
this prospective study found that vasectomy failure, based
on semen analysis results, is rare (0.8%). In addition, no
serious adverse events related to the vasectomy procedure
were reported.
The published literature on cautery occlusion methods is
difficult to interpret and evidence-based conclusions on
effectiveness of cautery for vas occlusion are difficult to
make [1]. Even in the U.S., a variety of vas occlusion meth-
ods are used [10] which may be a reflection of the limited
quality of data to support the use of any one occlusion
technique. In 1995 (the latest national data available),
71% of vasectomies in the U.S. were done using cautery,
up from 50% in 1991 [10,14].
In 10 published studies comparing ligation and cautery as
methods of vas occlusion, the failure rates based on
semen analysis ranged from 0–5% for cautery occlusion
[1]. Results of the two best quality studies comparing liga-
tion and excision to cautery (rated by the review paper's
authors as moderate quality) are conflicting; one study
found a higher failure risk based on semen analysis for
cautery [15] and the other found a lower risk [5].
Men appear to reach azoospermia sooner in terms of both
time and number of ejaculations following vasectomy by
cautery compared to ligation and excision. When ligation
and excision (with or without fascial interposition) were
used, the probability of achieving azoospermia was in the
range of 60–70% at 12–14 weeks postvasectomy [7,8,16].
We found that with cautery occlusion the probability of
achieving azoospermia was 85% at 12 weeks. Edwards
reported 100% azoospermia by 14 weeks with cautery
occlusion [17]. Men may also reach severe oligozoosper-
mia (< 100,000 sperm/mL) faster with cautery; the prob-
ability of success at 12 weeks was 95% in our study,
compared to recently published results of 91% at 14
Sperm concentration (number sperm per mL) categories by  week of follow-up (N = 389) Figure 3
Sperm concentration (number sperm per mL) cate-
gories by week of follow-up (N = 389).BMC Urology 2004, 4:10 http://www.biomedcentral.com/1471-2490/4/10
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weeks for ligation and excision with fascial interposition
and 82% for ligation and excision without fascial interpo-
sition [8].
The semen analysis patterns seen in the two vasectomy
failures which were not technical failures are suggestive of
very early recanalization given the extremely low sperm
numbers at 2 weeks followed by a gradual increases back
into the range of normal or potentially fertile sperm
counts (see Figure 2). This is similar to the patterns
reported for vasectomy failures when ligation and exci-
sion were used [7]. This concept of very early recanaliza-
tion–rapid declines in sperm numbers in the first few
weeks after vasectomy followed by a gradual rise back to
the normal range–has not been widely commented on in
the literature, most likely because early and frequent
semen analyses after vasectomy are unusual. An addi-
tional strength of this study was that semen analysis fol-
low-up continued after men achieved azoospermia. This
is unusual in the published literature on vasectomy and
provides a more detailed profile of sperm concentrations
of men following vasectomy.
Ideally, vasectomy success is confirmed by semen analy-
sis. In many low resource settings, however, semen analy-
sis is not readily accessible or available. Protocols
commonly used in these settings recommend 10–12
weeks or 15–20 ejaculations as endpoints for when men
can begin to rely on their vasectomy for contraception
[18,19]. Our data confirm results of two recent studies
which also showed that 12 weeks after vasectomy is more
reliable than 20 ejaculations as an endpoint and should
reduce the risk of failure [7,8]. Our finding that the predic-
tive value of one sample at 12 weeks for success at the end
of the study was 99.7% has practical implications for
vasectomy services. First, it suggests that one semen anal-
ysis at 12 weeks should be sufficient to indicate whether
or not a man could begin to rely on his vasectomy for con-
traception, and second, it is further evidence that 12 weeks
is a reasonable endpoint when semen analysis is not avail-
able, if cautery is used as the occlusion method.
Younger age accelerated success, with men younger than
35 years of age achieving both severe oligozoospermia
and azoospermia sooner than older men. A similar age
effect was seen when ligation and excision was used [8].
However, although statistically significant, the clinical sig-
nificance of the age effect, at least with cautery occlusion,
is likely to be minimal given the small absolute differ-
ences in probability of success between the age groups
(see Table 2).
Our study was not designed to analyze the efficacy of the
various occlusion procedures used at the study sites, but
rather to estimate effectiveness of occlusion techniques
that include use of cautery. Given the differences in the
occlusion techniques used at the study sites (see Figure 1),
it was not possible to determine any effect of the specific
aspects of the techniques (such as fascial interposition or
removal of a segment of vas), on overall success or failure.
The two failures that occurred due to apparent recanaliza-
tion were at the site using electrocautery without fascial
interposition or excision of a segment of the vas. Which of
the three specific aspects of the occlusion procedure may
have contributed to the vasectomy failures cannot be
determined.
The existing evidence in favor of using fascial interposi-
tion with cautery is weak [1]. However, fascial interposi-
tion has been shown to significantly improve the success
of vasectomy by ligation and excision [8]. Even fewer data
are available regarding differences in the effectiveness of
Table 2: Kaplan-Meier estimates of the probabilities of vasectomy success (N = 389). Probabilities of success by follow up week and age 
(< 35 or ≥ 35 years) for success defined as oligozoospermia and azoospermia.
Probability of success defined as oligozoospermia1 (95% 
CI)
Probability of success defined as azoospermia2 (95% CI)
Follow-up 
week
All participants Age < 35 years Age ≥ 35 years All participants Age < 35 years Age ≥ 35 years
2 44.9% (39.9, 49.8) 48.7% (40.8, 56.6) 42.3% (36.0,48.7) 25.8% (21.4, 30.1) 22.7% (16.1, 29.3) 27.8% (22.0, 33.5)
5 74.5% (70.1, 78.9) 77.9% (71.4, 84.5) 72.2% (66.5, 78.0) 58.2% (53.3, 63.1) 61.0% (53.3, 68.7) 56.3% (49.9, 62.7)
8 87.7% (84.3, 91.0) 90.0% (85.1, 95.0) 86.1% (81.7, 90.6) 73.6% (69.2, 78.1) 77.6% (70.8, 84.3) 71.0% (65.1, 76.9)
12 94.9% (92.7, 97.1) 97.2% (94.7, 99.6) 93.5% (90.3, 96.7) 85.3% (81.8, 88.9) 91.8% (87.4, 96.3) 81.1% (76.0, 86.2)
16 97.1% (95.3, 98.8) 97.9% (95.5, 100.0) 96.5% (94.2, 98.9) 90.2% (87.2, 93.3) 93.9% (90.0, 97.8) 87.9% (83.6, 96.3)
20 98.4% (97.0, 99.8) 99.3% (97.9, 100.0) 97.8% (95.7, 99.9) 94.0% (91.6, 96.5) 95.9% (92.7, 99.1) 92.8% (89.3, 96.3)
24 98.4% (95.3, 100.0) 99.3% (97.9, 100.0) 97.8% (93.6, 100.0) 98.0% (95.3, 100.0) 98.2% (94.7, 100.0) 98.1% (94.5, 100.0)
1less than 100,000 sperm/mL in two consecutive specimens at least two weeks apart with all subsequent samples showing only rare sperm. 2two 
consecutive specimens with no sperm at least two weeks apart with all subsequent samples showing only rare spermBMC Urology 2004, 4:10 http://www.biomedcentral.com/1471-2490/4/10
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thermal and electrocautery. A very small study found that
vas occlusion was more complete based on histologic
exam when thermal cautery was used [20] and a non-ran-
domized comparative trial found a higher, but nonsignif-
icant, risk of failure with electrocautery compared to
thermal cautery [15].
Data on the importance of removing a segment of the vas
are also limited. A recent study found no association
between the length of vas excised and the risk of recanali-
zation [21] and success has been reported when no vas tis-
sue is removed with occlusion by cautery combined with
fascial interposition [5,22-24]. Clearly, additional study is
needed before any evidence-based conclusions can be
made about the importance of the type of cautery, use of
fascial interposition, and excision of a segment of the vas
in reducing the risk of vasectomy failure.
One limitation of our study is that data are based on
semen analysis as opposed to pregnancy. The risk of preg-
nancy associated with oligozoospermia following vasec-
tomy–including the minimum sperm concentration that
could lead to pregnancy–is not well characterized. Results
from a study of male hormonal contraception showed
that it is necessary to reduce sperm counts to under 3
million per mL to achieve reliable contraception in men
with proven fertility [25]. These results, however, might
not be strictly comparable to the situation following
vasectomy. None the less, it is clear that the three vasec-
tomy failures seen here had sperm concentrations well
within the fertile range (Figure 2).
In addition, it is possible that recruitment bias could have
affected the study results. There was a wide variation in the
percent of men who agreed to participate in the study
(U.K. 98%, U.S. 96%, Brazil 70%, Canada 25%), which
appears to have been related to the convenience of provid-
ing semen samples at the different sites. We have no infor-
mation on men who declined to participate in the study,
although there are no obvious reasons why study out-
comes of the sort being measured here would differ sys-
tematically for men agreeing to participate relative to
those who did not. We cannot, however, rule this out as a
source of bias.
Conclusions
Despite the lack of data from randomized trials, evidence
is accumulating that the use of cautery for vas occlusion
reduces the likelihood of failure. We found failure based
on semen analysis to be rare following vasectomy by cau-
tery. Vasectomy success is best confirmed by semen anal-
ysis. However in settings where semen analysis is not
practical, using 12 weeks as a guideline for when men can
rely on their vasectomy for contraception should lessen
the risk of failure compared to using a guideline of 20
ejaculations after vasectomy. By 12 weeks after vasectomy,
nearly all men (96%) showed either severe oligozoosper-
mia or azoospermia, and the predictive values of one sam-
ple at 12 weeks for success at 24 weeks was 99.7%.
Additional research is needed to determine the impact of
the type of cautery, use of fascial interposition, and the
importance of excision of a segment of the vas on the risk
of failure associated with vasectomy by cautery.
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